Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2009, vol. 18, nr 1, January-February, p. 79–83

Publication type: review article

Language: English

Quality of Life in Inflammatory Bowel Disease

Jakość życia w nieswoistych zapaleniach jelit

Katarzyna Neubauer1,, Agata Arlukiewicz1,, Leszek Paradowski1,

1 Department of Gastroenterology and Hepatology Wroclaw Medical University, Poland

Abstract

Inflammatory bowel disease (IBD) is a chronic condition of unknown etiopathogenesis requiring continuous pharmacological treatment. Additionally, hospitalization and surgical intervention in the course of disease are often needed. Health−related quality of life in IBD is evaluated by general and IBD−specific questionnaires. Studies have shown significant correlation of the quality of life of patients with IBD with disease activity and significantly decreased quality of life during flares. Quality of life has become an important factor in evaluating the effectiveness of new therapeutic strategies in IBD IBD.

Streszczenie

Nieswoiste zapalenia jelit (Inflammatory Bowel Disease – IBD) to przewlekłe choroby przebiegające z okresami zaostrzeń i remisji, wymagające stałego leczenia farmakologicznego, a często również hospitalizacji i interwencji chirurgicznych. Jakość życia związana ze zdrowiem u pacjentów z IBD jest badana za pomocą kwestionariuszy ogólnych oraz swoistych, opracowanych specjalnie dla tych chorych. Badania jednoznacznie wskazują na związek jakości życia z aktywnością choroby i istotne obniżenie jakości życia w okresie zaostrzeń. Ocena jakości życia związanej ze zdrowiem stała się istotnym elementem w badaniu skuteczności nowych strategii terapeutycznych w IBD.

Key words

quality of life, IBDQ, inflammatory bowel disease, Crohn’s disease, ulcerative colitis

Słowa kluczowe

jakość życia, IBDQ, nieswoiste zapalenia jelit, choroba Leśniowskiego−Crohna, wrzodziejące zapalenie jelita grubego

References (29)

  1. Lakatos PL: Recent trends in the epidemiology of inflammatory disease: Up or down? World J Gastroenterol 2006, 12, 6102–6108.
  2. Paradowski L, Neubauer K, Kollbek P: Epidemiologia nieswoistych zapaleń jelit, skala problemu. Med Dypl 2007, Supl. 05/07, 33–37.
  3. Hanauer SB, Present DH: The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 2003, 3, 81–92.
  4. Ware JE Jr, Sherbourne CD: The MOS 36−item short−form health survey (SF−36). I. Conceptual framework and item selection. Med Care 1992, 30, 473–483.
  5. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96, 804–810.
  6. Irvine EJ: Quality of life – measurement in inflammatory bowel disease. Scand J Gastroenterol 1993, 28, Suppl. 199, 36–39.
  7. Reinisch W, Sandborn WJ, Bala M, Yan S, Feagan BG, Rugeerts P et al.: Response and remission are associated with improved quality of life, employment, and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis 2008, 13, 1135–1140.
  8. Satsangi J, Silverberg MS, Vermeire S, Colombel J−F: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55, 749–753.
  9. Love JR, Irvine EJ, Fedorak RN: Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992, 14, 15–19.
  10. Irvine EJ, Zhou Q, Thompson AK, the CCRPT Investigators: The Short Inflammatory Bowel Disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol 1996, 91, 1571–1579.
  11. Casellas F, Alcala MJ, Prieto L, Miro JR, Malagelada JR: Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol 2004, 99, 457–461.
  12. Alcala MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR: Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis 2004, 10, 383–391.
  13. Kiran RP, Delaney CP, Senagore AJ, O’Brien−Ermlich B, Mascha E, Thornton J, Fazio VW: Prospective assessment of Cleveland Global Quality of Life (CGQL) as a novel marker of quality of life and disease activity in Crohn’s disease. Am J Gastroenterol 2003, 98, 1781–789.
  14. Casellas F, Lopez Vivancos J, Malagela JR: Previous experience and quality of life in patients with inflammatory bowel disease during relapse. Rev Esp Enferm Dig 2003, 95, 476–479, 471–475.
  15. Andersson P, Olaison G, Bendtsen P, Myrelid P, Sjödahl R: Health related quality of life in Crohn’s proctocolitis does not differ from a general population when in remission. Colorectal Dis 2003, 5, 56–62.
  16. Cohen RD: The quality of life in patients with Crohn’s disease. Aliment Pharmacol Ther 2002, 16, 1603–1609.
  17. Casellas F, Vivancos JL, Sampedro M, Malagelada JR: Relevance of the phenotypic characteristics of Crohn’s disease in patient perception of health−related quality of life. Am J Gastroenterol 2005, 100, 2737–2742.
  18. Casellas F, Arenas JI, Baudet JS, Fabregas S, Garcia N, Gelabert J, Medina C, Ochotorena I, Papo M, Rodrigo L, Malagelada JR: Impairment of health−related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005, 11, 488–496.
  19. Kuriyama M, Kato J, Kuwaki K, Morimoto N, Nawa T, Fujimoto T, Kono H, Okano N, Miyaike J, Morita T, Okada H, Suzuki S, Yoshioka T, Shiode J, Suwaki K, Sakaguchi K, Shiratori Y: Japan West Ulcerative Colitis Study Group: Clinical factors that impair health−related quality of life in ulcerative colitis patients vary with the disease duration. Eur J Gastroenterol Hepatol 2008, 20, 634–641.
  20. Zahn A, Hinz U, Karner M, Ehehal R, Stremmel W: Health−related Quality of Life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis. Inflamm Bowel Dis 2006, 12, 1058–1067.
  21. Vidal A, Gomez−Gil E, Sans M, Portella MJ, Salamero M, Pique JM, Panes J: Health−related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis 2008, 14, 977–983.
  22. Coffey JC, Winter DC, Neary P, Murphy A, Redmond HP, Kirwan WO: Quality of life after ileal pouch−anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum 2002, 45, 30–38.
  23. Pallis AG, Mouzas IA, Vlachnikolis IG: The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis 2004, 10, 261–269.
  24. Han SW, McColl E, Steen N, Barton JR, Welfare MR: The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England. Scand J Gastroenterol 1998, 33, 961–966.
  25. Watanabe K, Funayama Y, Fukushima K, Shibata C, Takahashi K, Ogawa H, Haneda S, Kudo K, Kohyama A, Sasaki I: Study Group of Inflammatory Bowel Disease: Assessment of the Japanese Inflammatory Bowel Disease Questionnaire in patients after ileal pouch anal anastomosis for ulcerative colitis. J Gastroenterol 2006, 41, 662–667.
  26. Ren WH, Lai M, Chen Y, Irvine EJ, Zhou YX: Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis 2007, 13, 901–910.
  27. Leong RW, Lee YT, Ching JY, Sung JJ: Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the Inflammatory Bowel Disease Questionnaire. Aliment Pharmacol Ther 2003, 17, 711–718.
  28. Norman K, Kirchner H, Lochs H, Pirlich M: Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006, 21, 3380–3385.
  29. Lochs H, Delong C, Hammarqvist F, Hebuterne X, Leon−Sanz M, Schütz T, van Gemert W, van Gossum A, Valentini L, DGEM: Lübke H, Bischoff S, Engelmann N, Thul P: ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr 2006, 25, 260–274.
© Wroclaw Medical University